Erratum to: Psychopharmacology
DOI 10.1007/s00213-012-2680-6
Unfortunately, in the original publication of this article, the dose formulation was reported incorrectly. The section on Drugs in the “Materials and Methods” section should read as follows:
Drugs
Drugs and placebo were orally administered in size 0 aqua-colored opaque capsules with approximately 200 ml of water. Four identical capsules were administered in each drug session containing lactose monohydrate (Ruger Chemical Company, Linden, NJ, USA) and appropriate quantities of powdered dextromethorphan (Spectrum Chemical, Gardena, CA, USA) or triazolam tablets (Halcion; The Upjohn Company, Kalamazoo, MI, USA). Doses of dextromethorphan are expressed as the base.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s00213-012-2680-6.
Rights and permissions
About this article
Cite this article
Reissig, C.J., Carter, L.P., Johnson, M.W. et al. Erratum to: High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology 228, 513 (2013). https://doi.org/10.1007/s00213-013-3172-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-013-3172-z